{"id":"W2094565995","doi":"10.1002/acn3.192","title":"Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease","year":2015,"lang":"en","type":"article","venue":"Annals of Clinical and Translational Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Mental Health; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; National Institutes of Health; Genentech; IXICO; Servier; Eisai; Northern California Institute for Research and Education; University of California, San Diego; Pfizer; Biogen; BioClinica; Alzheimer's Disease Neuroimaging Initiative; Meso Scale Diagnostics; Synarc; Roche; University of Southern California; Medpace; Novartis Pharmaceuticals Corporation; Eli Lilly and Company; Bristol-Myers Squibb; F. Hoffmann-La Roche; Alzheimer's Drug Discovery Foundation; Alzheimer's Association; Foundation for the National Institutes of Health","keywords":"Medicine; Disease; Alzheimer's disease; Cognition; Clinical trial; Bioinformatics; Internal medicine; Psychiatry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2417061,0.00216918,0.006604284,0.002504712,0.0005952595,0.004167069,0.001218004,0.003037689,0.002799992],"category_scores_gemma":[0.3612941,0.001188651,0.003506436,0.002763125,0.001697573,0.006059345,0.002952777,0.003090024,0.0008485779],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001196553,"about_ca_system_score_gemma":0.003012571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001817939,"about_ca_topic_score_gemma":0.0002886821,"domain_scores_codex":[0.6581192,0.318851,0.0105833,0.004530279,0.007000746,0.000915499],"domain_scores_gemma":[0.7822006,0.1716087,0.02868684,0.009753,0.005455398,0.00229543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.1647903,0.002646146,0.1541633,0.01510482,0.02847721,0.000749063,0.000975883,0.06418169,0.006316477,0.02308562,0.009588637,0.5299209],"study_design_scores_gemma":[0.1528844,0.0789447,0.1657032,0.009443603,0.03297252,0.001633201,0.0006506797,0.1970095,0.01191854,0.2713648,0.07667698,0.0007978669],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.2514724,0.1095867,0.5593463,0.0219063,0.003042186,0.03506007,0.002264027,0.001367426,0.01595473],"genre_scores_gemma":[0.7053159,0.005112393,0.2573351,0.004569974,0.001334916,0.024446,0.0006145561,0.0001545795,0.001116616],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.2417061,"threshold_uncertainty_score":0.9351114,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3683324295590978,"score_gpt":0.5170352717315262,"score_spread":0.1487028421724284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}